BioSpace News Archive

The Urology Care Foundation, the official foundation of the American Urological Association, announced Arthur L. “Bud” Burnett, II, MD has been named to the Urology Care Foundation Board of Directors.

New Bayer herbicide provides excellent control of wild oat, plus other grass and broadleaf weeds in durum, spring and winter wheat

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase an additional 585,937 shares of common stock

Amgen (NASDAQ: AMGN) will present at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference at 4:00 p.m. ET on Tuesday, June 23, 2020.

miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced the appointment of Lee Rauch as Chief Operating Officer, effective immediately.

Kaiser Permanente, the nation’s largest nonprofit, integrated health system, announced that it is joining with nonprofit Civica Rx in its mission of assuring that health providers nationally have access to stable and affordable supplies of essential generic medications throughout the COVID-19 pandemic and beyond.

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today announced David A. Spellman is joining Akebia as its new Senior Vice President, Chief Financial Officer and Treasurer, effective June 29, 2020.

Mylan N.V. (NASDAQ: MYL) today announced that the U.S. District Court for the Northern District of West Virginia invalidated Biogen’s Tecfidera® patent, U.S. Patent No. 8,399,514, for lack of written description.

Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will participate in a fireside chat as part of the virtual BofA Securities Napa Biopharma Conference on Wednesday, June 24, 2020 at 3:30 PM EDT / 12:30 PM PDT.

The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic